In humans, recent clinical surveys have demonstrated that higher levels of IgM anti-PC are associated with less active disease in SLE and protection from cardiovascular disease in both SLE and non-autoimmune patients [12], [13], [49]–[51]. Here, CD40LG is linked to systemic lupus erythematosus.